Glomerulonephritis-induced changes in urinary and kidney microRNA profiles in rats

Toxicological Sciences

Volumn 145, Issue 2, 2015, Pages 348-359

  Pavkovic, Mira ^a,b   Riefke, Björn ^a   Frisk, Anna Lena ^a   Gröticke, Ina ^a   Ellinger Ziegelbauer, Heidrun ^a  

^a BAYER PHARMA AG   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biomarker; Glomerulonephritis; Urinary microRNAs

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; CLUSTERIN; CREATININE; CYSTATIN C; IMMUNOGLOBULIN M; KIDNEY INJURY MOLECULE 1; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 100; MICRORNA 10A; MICRORNA 10B; MICRORNA 146B; MICRORNA 184; MICRORNA 192; MICRORNA 197; MICRORNA 21; MICRORNA 211; MICRORNA 26A; MICRORNA 34A; MICRORNA 34B; MICRORNA 486; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; GENETIC MARKER; MIRN10 MICRORNA, RAT; MIRN100 MICRORNA, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; INTERACTIONS WITH RNA; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; NEPHRON; NEPHROTOXICITY; NONHUMAN; RAT; TREATMENT DURATION; URINE LEVEL; ACUTE KIDNEY FAILURE; ANIMAL; BIOPSY; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC MARKER; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TIME; URINE; WISTAR KYOTO RAT;

RATTUS;

ACUTE KIDNEY INJURY; ANIMALS; BIOPSY; CISPLATIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC MARKERS; GLOMERULONEPHRITIS; IN SITU HYBRIDIZATION; KIDNEY; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 84930750815     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfv053     Document Type: Article

References (58)

1. Abbate, M., Zoja, C., Rottoli, D., Corna, D., Tomasoni, S., and Remuzzi, G. (2002). Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int. 61, 2066-2077.
2. Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
3. Bob, F., Gluhovschi, G., Herman, D., Petrica, L., Bozdog, G., Gluhovschi, C., Velciov, S., Gadalean, F., Timar, R., Potencz, E., et al. (2014). Immunohistochemical study of tubular epithelial cells and vascular endothelial cells in glomerulonephritis. Ren. Fail. 36, 1208-1214.
4. Church, R. J., McDuffie, J. E., Sonee, M., Otieno, M., Ma, J. Y., Liu, X., Watkinsa, P. B., and Harrilla, A. H. (2014). MicroRNA-34c-3p is an early predictive biomarker for doxorubicin-induced glomerular injury progression in male Sprague-Dawley rats. Toxicol. Res. 3, 384-394.
5. Dieterle, F., and Sistare, F. (2010). Biomarkers of acute kidney injury. In Biomarkers: In Medicine, Drug Discovery, and Enviromental Health (V. S. Vaidya, and J. V. Bonventre, Eds.), pp. 237-263.
6. Hoboken, NJ: Wiley & Sons, Inc. Edgar, R., Domrachev, M., and Lash, A. E. (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210.
7. EMA. (2009). Final conclusions of the pilot joint EMEA/FDA VXDA experience on qualification of nephrotoxicity biomarkers. Available at: http://www.ema.europa.eu/docs/en_GB/document_ library/Regulatory_and_procedural_guideline/2009/10/WC500004205.pdf (Committee for medicinal products for human use).
8. Fu, Z., Qian, F., Yang, X., Jiang, H., Chen, Y., and Liu, S. (2014). Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer. Med. Oncol. 31, 164.
9. Fuchs, T. C., and Hewitt, P. (2011). Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: What we know and what we need to know. Biomark. Med. 5, 763-779.
10. Guengerich, F. P. (2011). Mechanisms of drug toxicity and relevance to pharmaceutical development. Drug Metab. Pharmacokinet. 26, 3-14.
11. Henique, C., Papista, C., Guyonnet, L., Lenoir, O., and Tharaux, P. L. (2014). Update on crescentic glomerulonephritis. Semin. Immunopathol. 36, 479-490.
12. Hermeking, H. (2012). MicroRNAs in the p53 network:Micromanagement of tumour suppression. Nat. Rev. Cancer 12, 613-626.
13. Hsu, R. K., McCulloch, C. E., Dudley, R. A., Lo, L. J., and Hsu, C. Y. (2013). Temporal changes in incidence of dialysis-requiring AKI. J. Am. Soc. Nephrol. 24, 37-42.
14. Huang, J. X., Blaskovich, M. A., and Cooper, M. A. (2014). Cell- and biomarker-based assays for predicting nephrotoxicity. Expert Opin. Drug Metabol. Toxicol. 10, 1621-1635.
15. Huang, X. R., Tipping, P. G., Apostolopoulos, J., Oettinger, C., D'Souza, M., Milton, G., and Holdsworth, S. R. (1997). Mechanisms of T cell-induced glomerular injury in antiglomerular basement membrane (GBM) glomerulonephritis in rats. Clin. Exp. Immunol. 109, 134-142.
16. Ichii, O., Otsuka-Kanazawa, S., Horino, T., Kimura, J., Nakamura, T., Matsumoto, M., Toi, M., and Kon, Y. (2014). Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS One 9, e110383.
17. Iida, T., Fujinaka, H., Xu, B., Zhang, Y., Magdeldin, S., Nameta, M., Liu, Z., Yoshida, Y., Yaoita, E., Tomizawa, S., et al. (2014). Decreased urinary calbindin 1 levels in proteinuric rats and humans with distal nephron segment injuries. Clin. Exp. Nephrol. 18, 432-443.
18. Jensen, O. N. (2004). Modification-specific proteomics:Characterization of post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol. 8, 33-41.
19. Jiang, X., Ning, Q., and Wang, J. (2013). Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts. J. Physiol. Sci. 63, 31-38.
20. Kanki, M., Moriguchi, A., Sasaki, D., Mitori, H., Yamada, A., Unami, A., and Miyamae, Y. (2014). Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats. Toxicology 324, 158-168.
21. Kawasaki, K., Yaoita, E., Yamamoto, T., and Kihara, I. (1992). Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int. 41, 1517-1526.
22. Konta, T., Ichikawa, K., Suzuki, K., Kudo, K., Satoh, H., Kamei, K., Nishidate, E., and Kubota, I. (2014). A microarray analysis of urinary microRNAs in renal diseases. Clin. Exp. Nephrol. 18, 711-717.
23. Kriegel, A. J., Liu, Y., Liu, P., Baker, M. A., Hodges, M. R., Hua, X., and Liang, M. (2013). Characteristics of microRNAs enriched in specific cell types and primary tissue types in solid organs. Physiol. Genomics 45, 1144-1156.
24. Krol, J., Loedige, I., and Filipowicz,W. (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610.
25. Kuroda, T., Yoshida, Y., Kamiie, J., Kovalenko, P., Nameta, M., Fujinaka, H., Yaoita, E., Endo, T., Ishizuka, S., Nakabayashi, K., et al. (2004). Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats. Clin. Exp. Nephrol. 8, 206-215.
26. Lai, J. Y., Luo, J., O'Connor, C., Jing, X., Nair, V., Ju, W., Randolph, A., Ben-Dov, I. Z., Matar, R. N., Briskin, D., et al. (2014). MicroRNA-21 in glomerular injury. J. Am. Soc. Nephrol. 26, 805-816.
27. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
28. miRBase. (2013). Available at: http://mirbase.org/. In Vol. 20. Faculty of Life Sciences at the University of Manchester with funding from the BBSRC, and was previously hosted and supported by the Wellcome Trust Sanger Institute.
29. Mall, C., Rocke, D. M., Durbin-Johnson, B., and Weiss, R. H. (2013). Stability of miRNA in human urine supports its biomarker potential. Biomark. Med. 7, 623-631.
30. Marshall, C. B., Krofft, R. D., Blonski, M. J., Kowalewska, J., Logar, C. M., Pippin, J. W., Kim, F., Feil, R., Alpers, C. E., and Shankland, S. J. (2011). Role of smooth muscle protein SM22alpha in glomerular epithelial cell injury. Am. J. Physiol. Renal Physiol. 300, F1026-F1042.
31. Nangaku, M., Alpers, C. E., Pippin, J., Shankland, S. J., Kurokawa, K., Adler, S., Johnson, R. J., and Couser, W. G. (1997). Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int. 52, 1570-1578.
32. Nassirpour, R., Mathur, S., Gosink, M. M., Li, Y., Shoieb, A. M., Wood, J., O'Neil, S. P., Homer, B. L., and Whiteley, L. O. (2014). Identification of tubular injury microRNA biomarkers in urine: Comparison of next-generation sequencing and qPCRbased profiling platforms. BMC Genomics 15, 485.
33. Nishimura, Y., Kondo, C., Morikawa, Y., Tonomura, Y., Torii, M., Yamate, J., and Uehara, T. (2015). Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats. J. Appl. Toxicol., 12, 173-180.
34. Pavkovic, M., Riefke, B., and Ellinger-Ziegelbauer, H. (2014a). Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury. Toxicology 324, 147-157.
35. Pavkovic, M., Riefke, B., Gutberlet, K., Raschke, M., and Ellinger-Ziegelbauer, H. (2014b). Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model. J. Pharmacol. Toxicol. Methods 69, 196-204.
36. Pusey, C. D. (2003). Anti-glomerular basement membrane disease. Kidney Int. 64, 1535-1550.
37. Ramachandran, K., Saikumar, J., Bijol, V., Koyner, J. L., Qian, J., Betensky, R. A., Waikar, S. S., and Vaidya, V. S. (2013). Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin. Chem. 59, 1742-1752.
38. Rokavec, M., Li, H., Jiang, L., and Hermeking, H. (2014). The p53/miR-34 axis in development and disease. J. Mol. Cell Biol. 6, 214-230.
39. Saikumar, J., Hoffmann, D., Kim, T. M., Gonzalez, V. R., Zhang, Q., Goering, P. L., Brown, R. P., Bijol, V., Park, P. J., Waikar, S. S., et al. (2012). Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol. Sci. 129, 256-267.
40. Saikumar, J., Ramachandran, K., and Vaidya, V. S. (2014). Noninvasive micromarkers. Clin. Chem. 60, 1158-1173.
41. Salant, D. J., and Cybulsky, A. V. (1988). Experimental glomerulonephritis. Methods Enzymol. 162, 421-461.
42. Schena, F. P., Serino, G., and Sallustio, F. (2014). MicroRNAs in kidney diseases: New promising biomarkers for diagnosis and monitoring. Nephrol. Dial. Transplant. 29, 755-763.
43. Small, E. M., and Olson, E. N. (2011). Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342.
44. Stahl, P. J., and Felsen, D. (2001). Transforming growth factorbeta, basement membrane, and epithelial-mesenchymal transdifferentiation: Implications for fibrosis in kidney disease. Am. J. Pathol. 159, 1187-1192.
45. Swain, A., Turton, J., Scudamore, C. L., Pereira, I., Viswanathan, N., Smyth, R., Munday, M., McClure, F., Gandhi, M., Sondh, S., et al. (2011). Urinary biomarkers in hexachloro-1:3-butadiene-induced acute kidney injury in the female Hanover Wistar rat; correlation of alpha-glutathione S-transferase, albumin and kidney injury molecule-1 with histopathology and gene expression. J. Appl. Toxicol. 31, 366-377.
46. Tam, F. W., Smith, J., Morel, D., Karkar, A. M., Thompson, E. M., Cook, H. T., and Pusey, C. D. (1999). Development of scarring and renal failure in a rat model of crescentic glomerulonephritis. Nephrol. Dial. Transplant. 14, 1658-1666.
47. Tian, Z., Greene, A. S., Pietrusz, J. L., Matus, I. R., and Liang, M. (2008). MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res. 18, 404-411.
48. Togashi, Y., Imura, N., and Miyamoto, Y. (2013). Urinary cystatin C as a renal biomarker and its immunohistochemical localization in anti-GBM glomerulonephritis rats. Exp. Toxicol. Pathol. 65, 1137-1143.
49. Urbschat, A., Obermuller, N., and Haferkamp, A. (2011). Biomarkers of kidney injury. Biomarkers 16(Suppl. 1), S22-S30.
50. Vaidya, V. S., Ferguson, M. A., and Bonventre, J. V. (2008). Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48, 463-493.
51. Vaidya, V. S., Ozer, J. S., Dieterle, F., Collings, F. B., Ramirez, V., Troth, S., Muniappa, N., Thudium, D., Gerhold, D., Holder, D. J., et al. (2010). Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat. Biotechnol. 28, 478-485.
52. Wang, G., Tam, L. S., Li, E. K., Kwan, B. C., Chow, K. M., Luk, C. C., Li, P. K., and Szeto, C. C. (2011). Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20, 493-500.
53. Wang, J., Gao, Y., Ma, M., Li, M., Zou, D., Yang, J., Zhu, Z., and Zhao, X. (2013). Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochem. Biophys. 67, 537-546.
54. Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271.
55. Wang, Y., Chen, T., and Tong, W. (2014). miRNAs and their application in drug-induced liver injury. Biomark. Med. 8, 161-172.
56. Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., Huang, K. H., Lee, M. J., Galas, D. J., and Wang, K. (2010). The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733-1741.
57. Zhou, C., Wu, J., Torres, L., Hicks, J. M., Bartkowiak, T., Parker, K., and Lou, Y. H. (2010). Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis. Am. J. Nephrol. 32, 324-331.
58. Zunino, F., and Capranico, G. (1990). DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anti-cancer Drug Des. 5, 307-317.